Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial
Michael Böhm(Saarland University), Benjamin Blossom, Tolga Agdirlioglu(Sana Klinikum), Barry Bertolet, Masahiko Asami, E. Andrikou, Kazuomi Kario(University of Pennsylvania), David P. Lee(APLA Health), Suhail Allaqaband, Kyle Bass, Stuart Pocock(London School of Hygiene & Tropical Medicine), James W. Choi(Baylor Jack and Jane Hamilton Heart and Vascular Hospital), Sebastian Ewen(Schwarzwald-Baar Klinikum), Felix Mahfoud(University of Basel), Vanessa DeBruin(Medtronic (United States)), Ahran Arnold, Jason Bloom, Faisal Sharif(Ollscoil na Gaillimhe – University of Galway), Michael A. Weber(SUNY Downstate Health Sciences University), David Reyes‐Leiva(Universitat Autònoma de Barcelona), Axel Schmid(Universitätsklinikum Erlangen), Raymond R. Townsend(University of Pennsylvania), William Bachinsky, Roland E. Schmieder(Universitätsklinikum Erlangen), Debbie L. Cohen(University of Pennsylvania), Denise Reedus, Cara East(Baylor Jack and Jane Hamilton Heart and Vascular Hospital), Christian Binner, Martin Fahy(Medtronic (United States)), Konstantinos Tsioufis(National and Kapodistrian University of Athens), David E. Kandzari(Piedmont Atlanta Hospital), Janice P. Lea, Herbert D. Aronow, Jiro Aoki, Yvonne Bewarder(Universitätsklinikum des Saarlandes), Karl Bihlmaier, Richard D’Souza(Royal Devon and Exeter Hospital), Chandan Devireddy, Sandeep Brar(Medtronic (United States)), John Barton, Andrew S.P. Sharp, Robert Wilensky, Chris Bell, Brian Jefferson(Centennial Medical Center), Adrian Ma(Stanford Health Care), Bryan Batson, Joachim Weil, Ertan Akarca, Sidney A. Cohen(University of Pennsylvania)
Cited by 586
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k